1. Home
  2. VSTA vs IPHA Comparison

VSTA vs IPHA Comparison

Compare VSTA & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vasta Platform Limited

VSTA

Vasta Platform Limited

HOLD

Current Price

$4.96

Market Cap

397.5M

Sector

Real Estate

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$1.84

Market Cap

174.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSTA
IPHA
Founded
1966
1999
Country
Brazil
France
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.5M
174.2M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
VSTA
IPHA
Price
$4.96
$1.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.00
AVG Volume (30 Days)
17.7K
22.5K
Earning Date
11-06-2025
09-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
$326,007,430.00
$14,839,695.00
Revenue This Year
$11.22
$22.29
Revenue Next Year
$13.43
$43.90
P/E Ratio
$4.24
N/A
Revenue Growth
13.60
N/A
52 Week Low
$1.60
$1.47
52 Week High
$5.49
$3.51

Technical Indicators

Market Signals
Indicator
VSTA
IPHA
Relative Strength Index (RSI) 47.41 42.81
Support Level $4.55 $1.85
Resistance Level $4.97 $1.91
Average True Range (ATR) 0.10 0.07
MACD -0.01 -0.00
Stochastic Oscillator 82.22 11.63

Price Performance

Historical Comparison
VSTA
IPHA

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: